drugset / Trial / NCT01756898

Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis

NCT01756898 ↗

Phase 2 Completed 370 enrolled Daiichi Sankyo
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this research study is to gather scientific information about the effectiveness of the study drug, ASB17061 capsules, when compared to placebo in adult subjects with atopic dermatitis.

Timeline

Start
2012-11-28
Primary completion
2014-01-14
Completion
2014-01-14

Drugs

EvaluationDrugModalityDoseRoute
Subject ASB17061 Unknown 5 mg Oral
Subject ASB17061 Unknown 10 mg Oral
Subject ASB17061 Unknown 20 mg Oral

Indications